Internal Medicine, Hematology & Oncology · Topsham, ME
NPI
1336346501
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
105 Topsham Fair Mall Rd Unit 1
Topsham, ME, 04086
Phone (207) 303-3300
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.9M
227,289 services
Medicare patients, 2024
372
Average age 76
Drug cost, 2024
$13.5M
2,756 prescriptions
Company payments, 2025
$243
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David C Benton was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 37,740 times for 28 patients. In total David C Benton billed 227,289 services in 172 codes, and Medicare paid $4.9M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-16.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 37,740 | 28 | $0.27 | $10K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 31,800 | 21 | $44.72 | $1.4M |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 26,040 | 17 | $2.33 | $61K |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 16,380 | 13 | $39.05 | $640K |
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 13,500 | 14 | $0.88 | $12K |
| J0897 Injection, denosumab, 1 mg | Office | 6,780 | 22 | $20.59 | $140K |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 6,430 | 20 | $35.70 | $230K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,037 | 41 | $0.09 | $184 |
| 85025 Blood Count | Office | 1,341 | 287 | $7.59 | $10K |
| 36415 Venipuncture Blood Collection | Office | 1,137 | 273 | $8.65 | $9,835 |
| 99214 Office E&M - Established | Office | 1,135 | 277 | $88.87 | $101K |
| 80053 Clinical Chemistry | Office | 1,108 | 228 | $10.35 | $11K |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 570 | 23 | $0.27 | $152 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 520 | 15 | $0.70 | $362 |
| 96375 Injection Administration | Office | 413 | 69 | $10.95 | $4,521 |
By year: 2022 $4.1M for 213,852 services; 2023 $4.7M for 213,721 services; 2024 $4.9M for 227,289 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,341 | 287 | $7.59 | $10K |
| 36415 Venipuncture Blood Collection | 1,137 | 273 | $8.65 | $9,835 |
| 80053 Clinical Chemistry | 1,108 | 228 | $10.35 | $11K |
| 82784 Immunoassay | 263 | 33 | $9.11 | $2,397 |
| 82728 Clinical Chemistry | 241 | 103 | $13.36 | $3,220 |
| 83540 Clinical Chemistry | 212 | 89 | $6.34 | $1,344 |
| 83550 Clinical Chemistry | 212 | 89 | $8.57 | $1,817 |
| 83521 Immunoassay | 202 | 43 | $16.93 | $3,419 |
| 84153 Clinical Chemistry | 170 | 41 | $18.02 | $3,063 |
| 84443 Clinical Chemistry | 114 | 46 | $16.46 | $1,876 |
Medicare prescription drug claims, 2024
In 2024, the drug David C Benton prescribed most often to Medicare patients was Abiraterone Acetate, with 283 prescriptions and refills. In total David C Benton wrote 2,756 Medicare prescriptions that cost $13.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Abiraterone Acetate Generic | 283 | 327 | 42 | $713K |
| Prednisone Generic | 276 | 391 | 65 | $2,036 |
| Eliquis Apixaban | 104 | 134 | 23 | $78K |
| Erleada Apalutamide | 103 | 106 | Under 11 | $1.5M |
| Revlimid Lenalidomide | 94 | 94 | 12 | $1.6M |
| Potassium Chloride Generic | 94 | 130 | 25 | $1,390 |
| Nubeqa Darolutamide | 88 | 88 | 11 | $1.2M |
| Orgovyx Relugolix | 85 | 85 | 12 | $230K |
| Letrozole Generic | 62 | 137 | 19 | $1,209 |
| Hydroxyurea Generic | 61 | 124 | 14 | $1,477 |
| Xarelto Rivaroxaban | 54 | 105 | 13 | $57K |
| Acyclovir Generic | 53 | 86 | 14 | $1,146 |
| Levothyroxine Sodium Generic | 52 | 90 | 14 | $416 |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 49 | 49 | Under 11 | $467K |
| Jakafi Ruxolitinib Phosphate | 49 | 51 | Under 11 | $674K |
Brand drugs: - claims; generic drugs: 1,584 claims; opioid claims: 20.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David C Benton $243 ($243 in general payments such as food, travel and fees) from 7 companies. The largest payer was Abbvie Inc. with $89.92.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.